Hershey Co (HSY) reported its fourth-quarter earnings for 2024, surpassing analysts' expectations with an earnings per share (EPS) of 2.69, compared to the forecasted 2.38. This beat, driven by ...

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

FLEX LNG Ltd. benefits from long-term charters, insulating it from current low spot market rates. Read more to see why FLNG ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on ...

ConocoPhillips (NYSE: COP) reported Q4 results, with $14.74B revenue and $1.98 EPS, surpassing expectations. Company also announced dividends and production targets for 2025.

Adjusted EBITDA of $996 M for the fourth quarter, $3,684 Mfor the full year;R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x ;R&D Solutions contracted ...

Yum Brands Q4 Worldwide Systems Sales Ex-Forex Up 8%; Opened 1,804 Gross Units in Q4… David Gibbs, CEO, said “2024 was marked with exceptional core operating profit growth given the complex consumer ...

Eli Lilly's Q4 revenue surged 45% to $13.53 billion, fueled by Mounjaro and Zepbound. 2025 guidance forecasts up to $61 billion in sales, driven by new drug launches.

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

EU mid-market update: BOE set to cut rates, but likely keeping its gradual stance; Maersk stays pessimistic regarding Red Sea return; Tokyo Electron beat helps global chip names.

Shares of FMC Corp. lost roughly a third of their value Wednesday, making the stock by far the biggest decliner in the S&P 500 after it reported a net loss for the fourth quarter.